hrcak mascot   Srce   HID

Izvorni znanstveni članak
https://doi.org/10.20471/acc.2019.58.02.15

Prognostic Significance of Cytoreductive Therapy of Ovarian Cancer –Eastern Croatia Experience

Zlatko Topolovec ; Department of Obstetrics and Gynecology, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Teodora Horvat ; Osijek University Hospital Centre, Osijek, Croatia
Domagoj Vidosavljević   ORCID icon orcid.org/0000-0002-0621-5403 ; Department of Obstetrics and Gynecology, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia; Department of Obstetrics and Gynecology, Vukovar General Hospital, Vukovar, Croatia
Siniša Šijanović ; Department of Obstetrics and Gynecology, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Andrijana Müller-Vranješ ; Department of Obstetrics and Gynecology, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Margareta Ugljarević ; Department of Obstetrics and Gynecology, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Dimitrije Milojković ; Department of Obstetrics and Gynecology, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Stjepan Topolovec ; Department of English Language and Literature, Faculty of Humanities and Social Sciences, University of Zagreb, Zagreb, Croatia

Puni tekst: engleski, pdf (642 KB) str. 311-319 preuzimanja: 68* citiraj
APA 6th Edition
Topolovec, Z., Horvat, T., Vidosavljević, D., Šijanović, S., Müller-Vranješ, A., Ugljarević, M., ... Topolovec, S. (2019). Prognostic Significance of Cytoreductive Therapy of Ovarian Cancer –Eastern Croatia Experience. Acta clinica Croatica, 58 (2.), 311-319. https://doi.org/10.20471/acc.2019.58.02.15
MLA 8th Edition
Topolovec, Zlatko, et al. "Prognostic Significance of Cytoreductive Therapy of Ovarian Cancer –Eastern Croatia Experience." Acta clinica Croatica, vol. 58, br. 2., 2019, str. 311-319. https://doi.org/10.20471/acc.2019.58.02.15. Citirano 20.10.2020.
Chicago 17th Edition
Topolovec, Zlatko, Teodora Horvat, Domagoj Vidosavljević, Siniša Šijanović, Andrijana Müller-Vranješ, Margareta Ugljarević, Dimitrije Milojković i Stjepan Topolovec. "Prognostic Significance of Cytoreductive Therapy of Ovarian Cancer –Eastern Croatia Experience." Acta clinica Croatica 58, br. 2. (2019): 311-319. https://doi.org/10.20471/acc.2019.58.02.15
Harvard
Topolovec, Z., et al. (2019). 'Prognostic Significance of Cytoreductive Therapy of Ovarian Cancer –Eastern Croatia Experience', Acta clinica Croatica, 58(2.), str. 311-319. https://doi.org/10.20471/acc.2019.58.02.15
Vancouver
Topolovec Z, Horvat T, Vidosavljević D, Šijanović S, Müller-Vranješ A, Ugljarević M i sur. Prognostic Significance of Cytoreductive Therapy of Ovarian Cancer –Eastern Croatia Experience. Acta clinica Croatica [Internet]. 2019 [pristupljeno 20.10.2020.];58(2.):311-319. https://doi.org/10.20471/acc.2019.58.02.15
IEEE
Z. Topolovec, et al., "Prognostic Significance of Cytoreductive Therapy of Ovarian Cancer –Eastern Croatia Experience", Acta clinica Croatica, vol.58, br. 2., str. 311-319, 2019. [Online]. https://doi.org/10.20471/acc.2019.58.02.15

Sažetak
The aim of this retrospective study was to present the impact of successful optimal cytoreductive therapy on the overall prognosis of ovarian cancer treatment. Several factors were analyzed, including clinical (stage, age and parity), histopathologic/cytological (histologic type and grade of tumors, cytological findings of ascites or peritoneal washout), and therapeutic (surgery performed with the degree of cytoreduction, adjuvant chemotherapy and response to therapy). The study included 126 patients treated during a 5-year period at the Department of Gynecology and Obstetrics, Osijek University Hospital Centre in Osijek. Patient age ranged from 29 to 82, total 5-year survival was 55.5% and median survival was 76.2 months. Optimal cytoreduction (residual tumor <1 cm) was performed in 49.2% of patients. On data analysis, the life chart method, χ2-test and Cox regression analysis were used. The level of significance was set at p<0.05. Parity, histologic tumor grade, presence of malignant cells in ascites and peritoneal washout, as well as clinical stage yielded statistical significance on univariate analysis. Cytoreductive ovarian cancer therapy turned out to be a significant prognostic factor and on multivariate analysis proven to be an independent prognostic factor. Optimal cytoreduction, besides direct effect on survival, improved the quality of therapeutic response of the tumor to chemotherapy.

Ključne riječi
Ovarian neoplasms; Cytoreduction surgical procedures; Prognosis; Retrospective studies; Chemotherapy, adjuvant; Croatia

Hrčak ID: 224452

URI
https://hrcak.srce.hr/224452

[hrvatski]

Posjeta: 236 *